Effects of nanocurcumin supplementation on T-helper 17 cells inflammatory response in patients with Behcet's disease: a randomized controlled trial.

Farzaneh, Rojin; Khabbazi, Alireza; Soltani-Zangbar, Mohammad Sadegh; Abbasian, Samaneh; Malek Mahdavi, Aida; Motavalli, Roza; Yousefi, Mehdi

Farzaneh, Rojin; Khabbazi, Alireza; Soltani-Zangbar, Mohammad Sadegh; Abbasian, Samaneh; Malek Mahdavi, Aida; Motavalli, Roza; Yousefi, Mehdi.

Afiliação

Farzaneh R; Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Khabbazi A; Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Soltani-Zangbar MS; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abbasian S; Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Malek Mahdavi A; Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Motavalli R; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Yousefi M; Rahat Breath and Sleep Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Immunopharmacol Immunotoxicol ; 44(2): 206-215, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35021944

Assuntos

Síndrome de Behçet; MicroRNAs; Síndrome de Behçet/tratamento farmacológico; Síndrome de Behçet/metabolismo; Citocinas/metabolismo; Suplementos Nutricionais; Humanos; MicroRNAs/genética; MicroRNAs/metabolismo; Células Th17

Palavras-chave

Behçet's disease; Thelper 17 cells; microRNA; nanocurcumin; proinflammatory cytokines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / MicroRNAs Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google